Drug General Information
Drug ID	D01PVV
Former ID	DCL000143
Drug Name	KD3010
Indication	Metabolic disease; Obesity [ICD9: 270-279, 278; ICD10:E66, E70-E89]		Phase 1	[551433]
Company	Kalypsys
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Peroxisomeproliferator activated receptor delta	Target Info	Agonist	[551433]
KEGG Pathway	PPAR signaling pathway
	Wnt signaling pathway
	Pathways in cancer
	Acute myeloid leukemia
NetPath Pathway	IL2 Signaling Pathway
PANTHER Pathway	Wnt signaling pathway
Pathway Interaction Database	Presenilin action in Notch and Wnt signaling
	RXR and RAR heterodimerization with other nuclear receptor
Reactome	Import of palmitoyl-CoA into the mitochondrial matrix
	Regulation of pyruvate dehydrogenase (PDH) complex
	Nuclear Receptor transcription pathway
WikiPathways	Wnt Signaling Pathway and Pluripotency
	Nuclear Receptors in Lipid Metabolism and Toxicity
	NRF2 pathway
	Nuclear Receptors Meta-Pathway
	Vitamin D Receptor Pathway
	Ectoderm Differentiation
	Adipogenesis
	Nuclear Receptors
References
Ref 551433	Kalypsys nearing completion of phase Ia study of KD3010 for metabolic disorders. Kalypsys. 2007.
Ref 551433	Kalypsys nearing completion of phase Ia study of KD3010 for metabolic disorders. Kalypsys. 2007.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.